background
influenza
zoonot
diseas
infect
million
peopl
year
result
hundr
thousand
death
turn
devast
pandem
influenza
caus
influenza
virus
includ
influenza
viru
iav
mani
subtyp
iav
seem
abl
adapt
human
caus
diseas
iav
subtyp
emerg
china
caus
clinic
symptom
chicken
host
lead
sever
infect
transmit
human
sinc
six
epidem
wave
laboratoryconfirm
human
infect
death
pathogen
iav
complex
crucial
featur
contribut
virul
activ
hemagglutinin
ha
fusion
protein
host
proteas
trigger
membran
fusion
lead
subsequ
viru
propag
vero
mdck
cell
use
conduct
western
blot
analysi
immunofluoresc
assay
pseudoparticl
live
viru
infect
evalu
ha
cleavageactiv
resultsconclus
show
human
matriptasest
abl
cleav
ha
cleavag
ha
express
cell
cultur
result
fusogen
ha
syncytia
format
infect
studi
viral
pseudoparticl
carri
matriptas
st
ha
observ
high
infect
cell
final
human
matriptasest
also
activ
live
viru
result
high
infect
data
demonstr
human
matriptasest
like
candid
proteas
promot
infect
human
influenza
virus
iav
circul
waterfowl
natur
reservoir
categor
base
antigen
properti
hemagglutinin
ha
neuraminidas
na
protein
differ
nine
differ
na
present
wild
bird
frequent
wild
bird
infect
poultri
result
cull
million
bird
signific
econom
loss
howev
wild
bird
rare
show
diseas
symptom
iav
poultri
usual
exhibit
respiratori
tropism
abl
mutat
highli
pathogen
form
influenza
also
zoonot
diseas
viru
occasion
transmit
infect
poultri
human
certain
ha
na
combin
howev
seem
favor
human
infect
caus
sever
devast
outbreak
human
past
spanish
flu
asian
pandem
hong
kong
pandem
swine
flu
respect
current
recent
emerg
strain
concern
global
public
health
lowpathogen
avian
influenza
lpai
first
discov
human
china
three
patient
hospit
sever
fatal
influenza
sinc
six
epidem
wave
result
laboratoryconfirm
human
infect
death
seventh
wave
current
ongo
intriguingli
viru
isol
outbreak
suggest
deriv
chicken
show
mild
symptom
diseas
investig
reveal
viral
gene
exclus
avian
origin
date
report
human
human
transmiss
even
though
exclud
case
howev
case
human
infect
attribut
exposur
human
infect
wild
bird
poultri
live
anim
market
crucial
step
life
cycl
influenza
subtyp
cleavag
ha
fusion
protein
host
proteas
ha
synthes
precursor
requir
proteolyt
process
exert
fusogen
activ
cleavag
occur
cterminu
fusion
peptid
result
exposur
allow
ha
induc
fusion
viral
cellular
membran
subsequ
releas
rna
host
cell
lpai
virus
monobas
cleavag
site
consist
singl
arginin
preced
three
amino
acid
influenza
subtypespecif
lpai
virus
wild
bird
usual
cleav
trypsin
gastrointestin
tract
trypsinlik
serin
proteas
human
poultri
resid
respiratori
tract
abl
process
virus
therefor
diseas
usual
confin
tissu
littl
known
activ
virus
previous
report
type
ii
transmembran
serin
proteas
play
role
cleavag
ha
activ
viru
mice
studi
show
knockout
ko
mice
highli
toler
infect
ko
mice
complement
human
mous
suscept
viru
restor
recent
report
human
matriptasest
abl
effici
cleav
cleavag
motif
peptid
mimic
matriptasest
membranebound
proteas
local
epitheli
cell
variou
tissu
human
seem
play
signific
role
activ
variou
influenza
subtyp
howev
result
obtain
use
cleavag
site
peptid
mimic
alway
reflect
vivo
situat
need
valid
show
human
matriptas
st
pcmvmlvgagpol
murin
leukemia
viru
mlv
packag
construct
ptgluc
transfer
vector
encod
luciferas
report
pcaggsvsvg
plasmid
describ
recombin
human
matriptasest
purchas
r
system
specif
activ
enzym
describ
fluorogen
peptid
substrat
bocqaramc
mm
nacl
ph
ad
one
well
incub
rocker
co
minut
control
mm
trypsin
pb
ad
minut
cell
process
western
blot
analysi
previous
describ
antibodi
detect
ha
obtain
biodefens
emerg
infect
research
resourc
repositori
secondari
antibodi
alexa
fluor
tag
purchas
invitrogen
western
blot
membran
scan
use
chemidoc
imag
system
biorad
facilit
exposur
linear
rang
band
quantifi
use
imagej
softwar
cleavag
effici
ha
calcul
follow
equat
ha
ha
ha
graph
gener
use
graphpad
prism
softwar
pseudoparticl
product
cell
grown
plate
transfect
ha
na
pcmvmlvgagpol
ptgluc
use
turbofect
accord
manufactur
recommend
control
transfect
pcaggsvsvg
pcmvmlvgagpol
ptgluc
posit
control
pcmvmlvgagpol
ptgluc
neg
control
supernat
harvest
hour
posttransfect
pseudoparticl
store
infect
cell
lysi
data
analysi
perform
previous
describ
experi
repeat
three
independ
time
result
plot
statist
analysi
conduct
use
graphpad
softwar
immunoplaqu
assay
previous
describ
experi
repeat
three
independ
time
data
statist
analysi
perform
use
graphpad
softwar
previous
report
recombin
human
matriptas
conclus
recombin
human
matriptasest
proteolyt
process
ha
abl
exert
fusogen
activ
establish
recombin
human
matriptasest
cleavag
result
fusogen
ha
protein
want
test
whether
would
promot
infect
viru
first
step
chose
produc
pseudoparticl
repres
surrog
nativ
virion
allow
us
studi
viral
entri
host
cell
pseudoparticl
use
assay
possess
mlv
core
incorpor
luciferas
report
gene
upon
releas
produc
cell
facilit
fusion
pseudovirion
contain
ha
incub
trypsin
matriptasest
prior
addit
cell
pseudoparticl
carri
vsvg
highli
infect
show
pseudoparticl
product
work
expect
figur
tabl
ha
pseudovirion
treat
trypsin
matriptasest
significantli
infecti
compar
pseudoparticl
without
proteas
treatment
figur
tabl
howev
signific
differ
trypsinand
matriptasest
pseudoparticl
suggest
pseudovirion
deplet
figur
tabl
pseudoparticl
without
incorpor
fusion
protein
infecti
data
show
matriptasest
cleavag
ha
result
fulli
infecti
virion
abl
fuse
host
cell
next
investig
whether
matriptasest
abl
sustain
promot
viral
growth
cell
cultur
system
therefor
infect
mdck
cell
live
viru
low
moi
ad
trypsin
matriptasest
control
receiv
proteas
treatment
hour
supernat
collect
viral
titer
quantifi
use
immunoplaqu
assay
influenza
treat
proteas
exhibit
titer
pfuml
figur
tabl
viru
treat
trypsin
matriptasest
howev
significantli
higher
titer
approxim
pfuml
respect
figur
tabl
